AVANTEC
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Nov 2025)
What this means for you
This application is over — abandoned 24 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97871034
- Mark type
- Stylized text
- Filed
- 03 Apr 2023
- Published for opposition
- 20 Feb 2024
- Abandoned
- 24 Nov 2025
- Attorney of record
- BRIAN S. BOYER, PH.D.
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for an implantable device that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for an implantable vascular device that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for a stent that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for a vascular stent that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of coatings for use on medical devices that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of vascular disease; Pharmaceutical preparations for the treatment and prevention of restenosis; Pharmaceutical preparations for the treatment and prevention of inflammation; None of the foregoing used for veterinary purposes
- Class 010 — Medical apparatus: Medical devices for use in treating vascular disease; Medical devices for use in treating a thrombosis; Medical devices for use in treating cardiovascular disease; Medical devices for use in treating atherosclerosis; Medical devices for use in treating restenosis; Surgical instruments, namely, interventional devices; Surgical instruments, namely, thrombectomy devices; Surgical instruments, namely, vascular surgery devices; Surgical instruments, namely, atherectomy devices; Surgical instruments, namely, vascular retrieval systems; Surgical instruments, namely, vascular guide wires; Surgical instruments, namely, vascular coil devices; Surgical instruments, namely, vascular coil delivery systems; Surgical instruments, namely, drug delivery devices; Surgical instruments, namely, vascular dilation devices; Surgical instruments, namely, vascular stent devices; Surgical instruments, namely, vascular stent delivery systems; Surgical instruments, namely, balloon dilatation devices
Owner
- AVANTEC VASCULAR CORPORATION, SUNNYVALE, CA, US
- AVANTEC VASCULAR CORPORATION, SUNNYVALE, CA, US
Prosecution history
- 24 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2025 — SOU EXTENSION 2 GRANTED
- 11 Dec 2024 — SOU EXTENSION 2 FILED
- 11 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2024 — SOU EXTENSION 1 GRANTED
- 22 Jul 2024 — SOU EXTENSION 1 FILED
- 22 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Feb 2024 — PUBLISHED FOR OPPOSITION